Renú Arturo, Laredo Carlos, Lopez-Rueda Antonio, Llull Laura, Tudela Raúl, San-Roman Luis, Urra Xabier, Blasco Jordi, Macho Juan, Oleaga Laura, Chamorro Angel, Amaro Sergio
From the Comprehensive Stroke Center, Department of Neuroscience, Hospital Clinic, University of Barcelona and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain (A.R., C.L., L.L., X.U., A.C., S.A.); Radiology Department, Hospital Clinic, Barcelona, Spain (A.L.-R., L.S.-R., J.B., J.M., L.O.); and CIBER de Bioingeniería, Biomateriales y Nanomedicina, Group of Biomedical Imaging of the University of Barcelona, Spain (R.T.).
Stroke. 2017 Mar;48(3):651-657. doi: 10.1161/STROKEAHA.116.015648. Epub 2017 Feb 7.
Less than half of acute ischemic stroke patients treated with mechanical thrombectomy obtain permanent clinical benefits. Consequently, there is an urgent need to identify mechanisms implicated in the limited efficacy of early reperfusion. We evaluated the predictors and prognostic significance of vessel wall permeability impairment and its association with blood-cerebrospinal fluid barrier (BCSFB) disruption after acute stroke treated with thrombectomy.
A prospective cohort of acute stroke patients treated with stent retrievers was analyzed. Vessel wall permeability impairment was identified as gadolinium vessel wall enhancement (GVE) in a 24- to 48-hour follow-up contrast-enhanced magnetic resonance imaging, and severe BCSFB disruption was defined as subarachnoid hemorrhage or gadolinium sulcal enhancement (present across >10 slices). Infarct volume was evaluated in follow-up magnetic resonance imaging, and clinical outcome was evaluated with the modified Rankin Scale at day 90.
A total of 60 patients (median National Institutes of Health Stroke Scale score, 18) were analyzed, of whom 28 (47%) received intravenous alteplase before mechanical thrombectomy. Overall, 34 (57%) patients had GVE and 27 (45%) had severe BCSFB disruption. GVE was significantly associated with alteplase use before thrombectomy and with more stent retriever passes, along with the presence of severe BCSFB disruption. GVE was associated with poor clinical outcome, and both GVE and severe BCSFB disruption were associated with increased final infarct volume.
These findings may support the clinical relevance of direct vessel damage and BCSFB disruption after acute stroke and reinforce the need for further improvements in reperfusion strategies. Further validation in larger cohorts of patients is warranted.
接受机械取栓治疗的急性缺血性卒中患者中,获得永久性临床获益的患者不到一半。因此,迫切需要确定与早期再灌注疗效有限相关的机制。我们评估了血管壁通透性受损的预测因素和预后意义,及其与急性卒中取栓治疗后血脑脊髓液屏障(BCSFB)破坏的关系。
分析了一组接受支架取栓治疗的急性卒中患者的前瞻性队列。血管壁通透性受损在24至48小时的随访对比增强磁共振成像中被确定为钆血管壁强化(GVE),严重的BCSFB破坏被定义为蛛网膜下腔出血或钆脑沟强化(跨越>10层)。在随访磁共振成像中评估梗死体积,并在第90天用改良Rankin量表评估临床结局。
共分析了60例患者(美国国立卫生研究院卒中量表评分中位数为18),其中28例(47%)在机械取栓前接受了静脉注射阿替普酶。总体而言,34例(57%)患者有GVE,27例(45%)有严重的BCSFB破坏。GVE与取栓前使用阿替普酶、更多的支架取栓次数以及严重BCSFB破坏的存在显著相关。GVE与不良临床结局相关,GVE和严重BCSFB破坏均与最终梗死体积增加相关。
这些发现可能支持急性卒中后直接血管损伤和BCSFB破坏的临床相关性,并强化了进一步改进再灌注策略的必要性。有必要在更大的患者队列中进行进一步验证。